Keith Belling sold $209k of RH
director at RH. 500 shares at an average of $417.85, traded Jan 6, 2025, filed Jan 7, 2025.
Score components
- +15RoleDirector
- +12Trade size$209k at market
- 0Share of holdings soldSold 9.1% of holdings
- +15Cluster3 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001415889-25-001064, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jan 6, 2025 | SOpen-market sale Common Stock | -500 | $417.85 | $209k | 4,970 | Jan 7, 2025 |
Related signals
Other insiders at RH and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 26Weak | RHsell RH | Mark S Demilio director | $132k 1,000 shares | -4% | |
| 33Weak | RH | Eri Chaya SEE REMARKS | $11M 25,000 shares | -100% | |
| 60Notable | RH | Christina Hargarten CHIEF ACCOUNTING OFFICER | $2.4M 5,280 shares | -92% | |
| 40Moderate | RH | Eri Chaya SEE REMARKS | $11M 25,000 shares | -100% | |
| 40Moderate | RH | Eri Chaya SEE REMARKS | $4.2M 10,000 shares | -100% | |
| 27Weak | RHsell RH | Keith Belling director | $208k 500 shares | -8% | |
| 41Moderate | RHsell RH | Edward T Lee SEE REMARKS | $707k 2,000 shares | -100% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.